Merriman Curhan Ford Maintains a 'Buy' on Cyclacel Pharmaceuticals (CYCC); Raises PT Range Feb 17, 2010 11:13AM
Cyclacel Pharma (CYCC) Announces Registered Direct Offering, to Raise Proceeds of $7.9M Jan 21, 2010 09:24AM
Cyclacel Pharma (CYCC) Enters Agreement to Raise $9.5M in Gross Proceeds from Direct Offering Jan 11, 2010 09:13AM
Cyclacel Pharmaceuticals (CYCC) Moves Up On Merriman Curhan's New "Buy" Rating, Aggressive Price Target Oct 28, 2009 08:49AM
Merriman Curhan Ford Initiates Coverage on Cyclacel Pharmaceuticals (CYCC) with a Buy Oct 28, 2009 07:34AM